Health & Fitness
In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers.
Click here to claim CE Credit.
More Episodes
Reducing ASCVD Risk in CKD
2024-10-30
389
2024-10-30
389
Exploring Solo Home Hemodialysis - A Team Sport
2024-06-11
1.1k
2024-06-11
1.1k
The Role of APP on the Nephrology Team
2024-03-29
947
2024-03-29
947
New Year, New You! – Leveraging Goal Setting in CKD Practice
2024-02-29
939
2024-02-29
939
Vitamin and Supplement Use in CKD
2024-01-31
2.0k
2024-01-31
2.0k
Holidays and CKD Part II
2023-11-30
1.3k
2023-11-30
1.3k
Hypertension and Pregnancy
2023-10-03
1.6k
2023-10-03
1.6k
Optimizing Kidney Health Care for LGBTQIA+ Patients
2023-07-11
1.8k
2023-07-11
1.8k
Working Towards Transplant
2023-05-25
2.4k
2023-05-25
2.4k
Living Donation and Transplant
2023-05-23
1.7k
2023-05-23
1.7k
Sexuality and Kidney Disease
2023-02-28
1.6k
2023-02-28
1.6k
Kidney Disease and the Holidays
2022-12-08
1.5k
2022-12-08
1.5k
Depression and Dialysis- Reviewing the ASCEND Study
2022-10-24
1.8k
2022-10-24
1.8k
Transitions of Care (AKI/CKD to Dialysis)
2022-09-27
1.8k
2022-09-27
1.8k
Breastfeeding
2022-09-09
1.1k
2022-09-09
1.1k
Dialysis Options
2022-07-15
1.8k
2022-07-15
1.8k
Salt Intake and CKD
2022-06-17
1.9k
2022-06-17
1.9k
Reproductive Health after Transplant
2022-05-24
1.1k
2022-05-24
1.1k
Get this podcast on your
phone, FREE
